Background: Under utilization of warfarin in
elderly patients with atrial fibrillation (AF) has been recognized as a
significant health care issue. This study examines the rate and reasons for
warfarin underutilization in elderly patients with AF at the Kansas City Veterans Affairs Medical Center.
Methods: Retrospective study reviewing electronic medical
records of all patients aged 65 and older with the diagnosis of atrial
fibrillation. Patients on warfarin were excluded. Reasons for not using
warfarin were extracted by reviewing the electronic medical record.
Anticoagulation indications for these patients were determined based on the
ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial
Fibrillation.
Results:Warfarin was not used by 407
patients (25%) with known AF. Average age was 79+6.2 years. 60% of
patients had persistent or permanent AF. Prevalence of risk factors for
thromboembolism included hypertension (74%), heart failure or ejection fraction
of <40% (21%), diabetes (27%) and coronary artery disease (48%). CHADS (2)
scores were documented in the charts less than 1% of the times. Only 11
patients had CHADS (2) score of 0 and 70 had a score of 1. A class I or IIa
indication for warfarin therapy was present in 298 (73%) of patients. Return to
sinus rhythm (37%) was the most common reason for not using warfarin. In 30% of
cases the reason not to use warfarin was not addressed. Other reasons not to
use warfarin included fear of falls (7%), prior head or GI bleed (14%), patient
refusal & noncompliance (12%). History of CVA or TIA was documented in 12%
of patients.
Conclusions:Underutilization of warfarin in
elderly patients with atrial fibrillation remains a common problem despite
their high risk for thromboembolic events. A false sense of security about the paroxysmal
nature of AF, lack of proper insight about stroke risk (CHADS (2)), and fear of
bleeding are the most common reasons for non use of warfarin.
Credits: Mazda Biria MD; Ahmad Batrash MD; Jayasree Piallarisetti MD; James Vacek MD; Loren Berenbom MD; Dhanunjaya Lakkireddy, MD